Laparoscopic radiofrequency ablation of hepatic cavernous hemangioma

Fan, Rengen; Chai, Fulu; He, Guan-xian; Wei, Lixin; Li, R.-Z.; Wan, W.-X.; Bai, Mei; Zhu, Wenjie; Cao, Minglu; Li, H.-M.; Yan, Su-zhi

doi:10.1007/s00464-005-0184-8

Cited by 28 publications

(16 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Gao et al 22 treated 36 hepatic hemangiomas with an average diameter of 10 ± 4 cm (5.0-21.5 cm) by RFA, the ablation time was 103 ± 27 min (40-160 min). Fan et al 23 reported that 27 patients with hepatic hemangiomas of 5.5 ± 2.0 cm in diameter were treated by laparoscopic RFA, in whom the average RFA time was 20.7 ± 11.9 min. In another report 24 the average RFA time was 60.5 ± 36.2 min (range 27-208 min).…”

Section: Discussionmentioning

confidence: 99%

Efficacy, safety and feasibility of ultrasound‐guided percutaneous microwave ablation for large hepatic hemangioma

Tang

Wang

et al. 2015

J of Digest Diseases

View full text Add to dashboard Cite

OBJECTIVE:To evaluate the efficacy, safety and feasibility of microwave ablation (MWA) for large (5-10 cm in diameter) hepatic hemangioma. METHODS:In all, 46 patients with 47 large hepatic hemangiomas were treated with ultrasound-guided percutaneous MWA. The effect of MWA for all patients was evaluated by enhanced magnetic resonance imaging or computed tomography within two months after ablation. RESULTS:A total of 27 male and 19 female patients were enrolled, with an average age of 46 ± 11 years. The average size of hemangiomas was 6.3 ± 1.4 cm (range 5.0-9.6 cm). The initial complete ablation rate was 91.5% (43/47) and the volume of ablated lesions was significantly reduced. The rate of complete necrosis was not associated with the tumor size or location (P = 0.899 and 0.758, respectively). The total complete ablation rate was 95.7% (45/47). Major complications included acute renal dysfunction, hyperbilirubinemia and pleural effusion. No procedure-related death occurred. The average hospitalization stay was 5.7 ± 2.5 days (range 3-17 days). During a follow-up period of 18.2 months (range 4-40 months), one patient developed local tumor progression at the radiofrequency ablation site. Three patients had new hemangiomas in other sites of the liver. At the end of the study all patients were alive and no severe complications occurred. CONCLUSION:Image-guided MWA is an effective and safe treatment for large hepatic hemangiomas, and can potentially be regarded as the first-line therapy.

show abstract

Section: Discussionmentioning

confidence: 99%

Efficacy, safety and feasibility of ultrasound‐guided percutaneous microwave ablation for large hepatic hemangioma

Tang

Wang

et al. 2015

J of Digest Diseases

View full text Add to dashboard Cite

show abstract

“…Thyroid hormone replacement therapy, in some degree, can treat hypothyroidism due to excessive resection of thyroid tissue.However, the efficacy of drug treatment is also controversial, andsome literature repored that levothyroxine had no obvious effects ininhibiting nodules10. Radiofrequency ablation (RFA), as a new minimally invasive treatment techonology developed in recent years, had been applied frequently in the treating abdominal cancer11, 12. With the maturation of this technology, RFA has been successfully applied in treating benign thyroid nodules or recurrent thyroid cancer in foreign countries13, 14.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of the safety and efficacy of radiofrequency ablation for treating benign thyroid nodules

Tang¹,

Cui²,

Chi³

et al. 2017

J. Cancer

View full text Add to dashboard Cite

Background: Radiofrequency ablation (RFA) is a relatively new procedure for treating benign thyroid nodules. The purpose of this study was to evaluate the safety and efficacy of RFA for treating benign thyroid nodules so as to serve as a reference for future clinical practice.Methods: This study retrospectively analyzed the clinical data of patients receiving percutaneous RFA for treating thyroid nodules from November 2014 to July 2015 in our medical center. One hundred and eight patients with a total of 380 nodules received ultrasound-guided RFA for treating thyroid nodules. Comparisons of the volume change of thyroid nodules before and after RFA treatment, post-treatment complication, and change of thyroid function, were carried out afterwards.Results: Before treatments, all patients received fine needle aspiration biopsy (FNA) which supported the diagnosis of benign tumor. There were 13 males and 95 females included in the study. Twenty-six cases (24.07%) had single nodule, and 82 cases (75.93%) had multiple nodules. Before treatments, the thyroid functions (FT3, FT4, and TSH) were normal originally or adjusted to normal range by endocrinology treatment. The preoperative nodules had minimum volume of 0.01mL, maximum volume of 70.89 mL, and mean volume of 1.02 ± 4.24mL. The volume of nodules one month and three months after RFA were 0.29 ± 0.72mL and 0.15 ± 0.87mL, respectively. In addition, volume reduction ratio (VRR) of nodules one month and three months after RFA were 64.12% and 85.54%, respectively. Both volume of nodules and VRR had statistically significant differences for pre-operative and post-operative comparison (P<0.05). Thyroid functions were in normal range after treatments, and there was no serious complications.Conclusions: Ultrasound-guided RFA treating benign thyroid nodules had the advantages of definite efficacy, safety, strong in control ability, no incision, less damage to surrounding normal tissues and no effect on thyroid function. It can be used as one of the main treatment methods for treating benign thyroid nodules.

show abstract

“…Laparoscopic RFA, without resection, has been used to treat HH. Fan et al reported 27 patients treated with laparoscopic RFA with no recurrence at a mean of 21 months 17 . Still, the authors recommend that tumors larger than 10 cm be treated open with resection to prevent risk of massive bleeding.…”

Section: Discussionmentioning

confidence: 99%

Use of radiofrequency hepatic parenchymal transection device in hepatic hemangioma resection: early experience and lessons learned

Hering

Garrean

Saied

et al. 2007

HPB

View full text Add to dashboard Cite

show abstract

Laparoscopic radiofrequency ablation of hepatic cavernous hemangioma

Cited by 28 publications

References 19 publications

Efficacy, safety and feasibility of ultrasound‐guided percutaneous microwave ablation for large hepatic hemangioma

Efficacy, safety and feasibility of ultrasound‐guided percutaneous microwave ablation for large hepatic hemangioma

Evaluation of the safety and efficacy of radiofrequency ablation for treating benign thyroid nodules

Use of radiofrequency hepatic parenchymal transection device in hepatic hemangioma resection: early experience and lessons learned

Contact Info

Product

Resources

About